Copy number alterations of EGFR and FGFR1 in pulmonary carcinosarcoma

被引:0
|
作者
Tajima, Shogo [1 ]
Koda, Kenji [1 ]
机构
[1] Fujieda Municipal Gen Hosp, Dept Pathol, Shizuoka 4268677, Japan
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2016年 / 9卷 / 03期
关键词
Carcinosarcoma; EGFR; FGFR1; fluorescence in situ hybridization; immunohistochemistry; SQUAMOUS-CELL CARCINOMA; URINARY-BLADDER; LUNG-CANCER; AMPLIFICATION; EXPRESSION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinosarcoma may develop through sarcomatoid changes in a carcinoma, known as epithelial-mesenchymal transition, or may develop from a single cancer stem cell and subsequently diverge into morphologically dissimilar carcinomatous and sarcomatous components. Thus, we tried to elucidate the histogenesis of pulmonary carcinosarcoma, which has not been thoroughly examined. A key approach to the investigation was use of fluorescence in situ hybridization analysis of EGFR and FGFR1, because the carcinomatous component of the carcinosarcoma of the available sample was a squamous cell carcinoma, which tends to harbor copy number gain in EGFR and FGFR1. Consequently, it was postulated that the carcinosarcoma originated from cancer stem cells polysomic for EGFR, and only the carcinomatous component received FGFR1 amplification during divergence into carcinomatous and sarcomatous components.
引用
收藏
页码:3187 / 3194
页数:8
相关论文
共 50 条
  • [1] Increased FGFR1 copy number in lung squamous cell carcinomas
    Sasaki, Hidefumi
    Shitara, Masayuki
    Yokota, Keisuke
    Hikosaka, Yu
    Moriyama, Satoru
    Yano, Motoki
    Fujii, Yoshitaka
    MOLECULAR MEDICINE REPORTS, 2012, 5 (03) : 725 - 728
  • [2] IMPORTANCE OF COPY NUMBER ALTERATIONS OF FGFR1 AND C-MYC GENES IN TRIPLE NEGATIVE BREAST CANCER
    Nedeljkovic, Milica
    Tanic, Nikola
    Dramicanin, Tatjana
    Milovanovic, Zorka
    Susnjar, Snezana
    Milinkovic, Vedrana
    Vujovic, Ivana
    Prvanovic, Mirjana
    Tanic, Nasta
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2019, 38 (01) : 63 - 70
  • [3] Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung
    Mendez, Pedro
    Luis Ramirez, Jose
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (02) : 101 - 111
  • [4] Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer
    Tran, Thang N.
    Selinger, Christina I.
    Kohonen-Corish, Maija R. J.
    McCaughan, Brian C.
    Kennedy, Catherine W.
    O'Toole, Sandra A.
    Cooper, Wendy A.
    LUNG CANCER, 2013, 81 (03) : 462 - 467
  • [5] FGFR1 expression and gene copy numbers in human lung cancer
    Kohler, Lukas H.
    Mireskandari, Masoud
    Knoesel, Thomas
    Altendorf-Hofmann, Annelore
    Kunze, Almut
    Schmidt, Andreas
    Presselt, Norbert
    Chen, Yuan
    Petersen, Iver
    VIRCHOWS ARCHIV, 2012, 461 (01) : 49 - 57
  • [6] FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer
    Yang, Ying
    Lu, Tingting
    Li, Ziming
    Lu, Shun
    CELL ADHESION & MIGRATION, 2020, 14 (01) : 82 - 95
  • [7] FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
    Quintanal-Villalonga, Alvaro
    Molina-Pinelo, Sonia
    Cirauqui, Cristina
    Ojeda-Marquez, Laura
    Marrugal, Angela
    Suarez, Rocio
    Conde, Esther
    Ponce-Aix, Santiago
    Enguita, Ana Belen
    Carnero, Amancio
    Ferrer, Irene
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : 641 - 655
  • [8] Clinical and Molecular Features of Lung Cancers with Increased FGFR1 mRNA and/or Gene Copy Number
    Ng, T.
    Yu, H.
    York, E.
    Leedy, S.
    Gao, D.
    Heasley, L.
    Hirsch, F. R.
    Camidge, D. R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2101 - S2101
  • [9] FGFR1 copy number in breast cancer: associations with proliferation, histopathological grade and molecular subtypes
    Bofin, Anna M.
    Ytterhus, Borgny
    Klaestad, Elise
    Valla, Marit
    JOURNAL OF CLINICAL PATHOLOGY, 2022, 75 (07) : 459 - 464
  • [10] Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells
    Terp, Mikkel G.
    Jacobsen, Kirstine
    Angel Molina, Miguel
    Karachaliou, Niki
    Beck, Hans C.
    Bertran-Alamillo, Jordi
    Gimenez-Capitan, Ana
    Cardona, Andres F.
    Rosell, Rafael
    Ditzel, Henrik J.
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)